← back to database
Flagship Pioneering
HQ · Massachusetts
Flagship invents, creates, resources, and builds platform companies that develop breakthrough technologies for human health and sustainability. It develops original scientific ideas into companies and supports them from company creation through growth.
Stage focus
Lead / follow
Specialization
Generalist / Specialist
Specialist
Latest fund size
$2.6B Raised into Fund VIII
Latest fund vintage
2024
Other specialization
Company creation and platform investing in human health, sustainability, AI-enabled science, and transformative technologies.
Investing team
- Noubar Afeyan, Ph.D.Founder and CEO ()
- Doug Cole, M.D.Managing Partner ()
- Paul BiondiManaging Partner ()
- Yvonne HaoCOO and General Partner ()
- Maggie SahlmanExecutive Partner; Head of Fundraising and Investor Relations ()
Notable investments
Lila Sciences — 2025-03-10 — New company launch and committed seed financing Expedition Medicines — 2025-10-22 — New company launch with initial Flagship commitment
Sources
flagshippioneering.com/contact ↗flagshippioneering.com/news/press-release/flagship-pioneering-raises-3-6-billion-to-fuel-breakthrough-innovations-that-transform-human-health-and-sustainability ↗flagshippioneering.com/news/press-release/flagship-pioneering-unveils-lila-sciences-to-build-superintelligence-in-science ↗flagshippioneering.com/news/press-release/flagship-pioneering-unveils-expedition-medicines-to-expand-the-boundaries-of-small-molecule-medicines-with-generative-design ↗flagshippioneering.com/news/press-release/flagship-pioneering-strengthens-leadership-team-with-two-executive-appointments ↗flagshippioneering.com/principles ↗flagshippioneering.com ↗